Current Colorectal Cancer Reports

, Volume 8, Issue 1, pp 16–21 | Cite as

Is There a Place for Screening Flexible Sigmoidoscopy?

Prevention and Early Detection (N Arber, Section Editor)


Flexible sigmoidoscopy is a valid screening tool for the early detection of colorectal cancer (CRC). Recently published long-term data from UKFSST, a randomized controlled trial, demonstrate a 33% reduction in colorectal cancer incidence and a 43% decrease in colorectal cancer mortality, with once-in-a-lifetime screening. On the other hand, data from the NORCCAP trial with a similar protocol show no reduction in CRC incidence and only nonsignificant decrease in CRC mortality at 7 years. At best, flexible sigmoidoscopy can detect only 70% of cancers and polyps as it does not detect the 40% of proximal neoplasms which are not associated with a distal lesion. The advantage of flexible sigmoidoscopy over other screening modalities lies in its safety profile, patient tolerance, and overall acceptance. Its technical simplicity, short duration, and cost-effectiveness advance its applicability to mass screening programs.


Flexible sigmoidoscopy Screening Colorectal cancer Prevention and early detection 


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology. 2003;124:544–60.PubMedCrossRefGoogle Scholar
  2. 2.
    Calonge N, Petitti DB, DeWitt TG, et al. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. preventive services task force recommendation statement. Ann Int Med. 2008;149:627–37.Google Scholar
  3. 3.
    •• Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58:130–60. This article outlines the latest screening and surveillance guidelines for colorectal cancer and polyps in the United States. PubMedCrossRefGoogle Scholar
  4. 4.
    Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009;104:739–50.PubMedCrossRefGoogle Scholar
  5. 5.
    Lieberman DA, Weiss DG, Bond JH, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000;343:162–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Imperiale TF, Wagner DR, Lin CY, et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000;343:169–74.PubMedCrossRefGoogle Scholar
  7. 7.
    Thiis-Evensen E, Hoff GS, Sauar J, et al. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer: Telemark Polyp Study I. Scand J Gastroenterol. 1999;34:414–20.PubMedCrossRefGoogle Scholar
  8. 8.
    Hoff G, Thiis-Evensen E, Grotmol T, et al. Do undesirable effects of screening affect all-cause mortality in flexible sigmoidoscopy programmes? experience from the Telemark Polyp Study 1983–1996. Eur J Canc Prev. 2001;10:131–7.CrossRefGoogle Scholar
  9. 9.
    Atkin WS, Hart A, Edwards R, et al. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut. 1998;42:560–5.PubMedCrossRefGoogle Scholar
  10. 10.
    •• Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375:1624–33. A landmark randomized controlled study that established flexible sigmoidoscopy role in screening for colorectal cancer. PubMedCrossRefGoogle Scholar
  11. 11.
    Hoff G, Grotmol T, Skovlund E, Bretthauer M. Risk of colorectal cancer 7 years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ. 2009;338:1846.CrossRefGoogle Scholar
  12. 12.
    Segnan N, Senore C, Andreoni B, et al. Baseline findings of the Italian multicenter randomized controlled trial of “once-only sigmoidoscopy”–SCORE. J Natl Canc Inst. 2002;94:1763–72.CrossRefGoogle Scholar
  13. 13.
    Weissfeld JL, Schoen RE, Pinsky PF, et al. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Canc Inst. 2005;97:989–97.CrossRefGoogle Scholar
  14. 14.
    Selby JV, Friedman GD, Quesenberry CP, et al. A case–control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. Arch Intern Med. 1995;155:1741–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Kavanagh AM, Giovannucci EL, Fuchs CS, et al. Screening endoscopy and risk of colorectal cancer in United States men. Canc Causes Contr. 1998;9:455–62.CrossRefGoogle Scholar
  17. 17.
    Newcomb PA, Norfleet RG, Storer BE, et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Canc Inst. 1992;84:1572–5.CrossRefGoogle Scholar
  18. 18.
    Slattery ML, Edwards SL, Ma KN, et al. Colon cancer screening, lifestyle, and risk of colon cancer. Canc Causes Contr. 2000;11:555–63.CrossRefGoogle Scholar
  19. 19.
    Levin TR, Conell C, Shapiro JA, et al. Complications of screening flexible sigmoidoscopy. Gastroenterology. 2002;123:1786–92.PubMedCrossRefGoogle Scholar
  20. 20.
    Anderson ML, Pasha TM, Leighton JA. Endoscopic perforation of the colon: lessons from a 10-year study. Am J Gastroenterol. 2000;95:3418–22.PubMedCrossRefGoogle Scholar
  21. 21.
    • Denis B, Gendre I, Aman F, et al. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial). Eur J Cancer. 2009;45:3282–90. A well-designed study that suggested the combination of flexible sigmoidoscopy and fecal occult blood testing in screening for colorectal cancer. PubMedCrossRefGoogle Scholar
  22. 22.
    Hoff G, Vatn M, Gjone E, et al. Epidemiology of polyps in the rectum and sigmoid colon. Design of a population screening study. Scand J Gastroenterol. 1985;20:351–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Collett JA, Olynyk JK, Platell CF. Flexible sigmoidoscopy screening for colorectal cancer in average-risk people: update of a communitybased project. Med J Aust. 2000;173:463–6.PubMedGoogle Scholar
  24. 24.
    Hol L, de Jonge V, van Leerdam ME, et al. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy. Eur J Cancer. 2010;46:2059–66.PubMedCrossRefGoogle Scholar
  25. 25.
    Eloubeidi MA, Wallace MB, Desmond R, Farraye FA. Female gender and other factors predictive of a limited screening flexible sigmoidoscopy examination for colorectal cancer. Am J Gastroenterol. 2003;98:1634–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Walter LC, de Garmo P, Covinsky KE. Association of older age and female sex with inadequate reach of screening flexible sigmoidoscopy. Am J Med. 2004;116:174–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Viiala CH, Olynyk JK. Reasons for noncompliance with five-yearly screening flexible sigmoidoscopy. Patient Prefer Adherence. 2008;2:27–33.PubMedCrossRefGoogle Scholar
  28. 28.
    Atkin WS, Cook CF, Cuzick J, et al. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet. 2002;359:1291–300.PubMedCrossRefGoogle Scholar
  29. 29.
    Schneider A, Kanagarajan N, Anjelly D, et al. Importance of gender, socioeconomic status, and history of abuse on patient preference for endoscopist. Am J Gastroenterol. 2009;104:340–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Farraye FA, Wong M, Hurwitz S, et al. Barriers to endoscopic colorectal cancer screening: are women different from men? Am J Gastroenterol. 2004;99:341–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Lembo T, Fitzgerald L, Matin K, et al. Audio and visual stimulation reduces patient discomfort during screening flexible sigmoidoscopy. Am J Gastroenterol. 1998;93:1113–6.PubMedCrossRefGoogle Scholar
  32. 32.
    Fich A, Efrat R, Sperber AD, et al. Nitrous oxide inhalation as sedation for flexible sigmoidoscopy. Gastrointest Endosc. 1997;45:10–2.PubMedCrossRefGoogle Scholar
  33. 33.
    Dumot JA, Verzola E, Nicol S, et al. Sublingual hyoscyamine for patient comfort during screening sigmoidoscopy: a randomized, double-blind, placebo-controlled clinical trial. Gastrointest Endosc. 1998;48:283–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Kuganeswaran E, Clarkston WK, Cuddy PG, et al. A double-blind placebo controlled trial of oral midazolam as premedication before flexible sigmoidoscopy. Am J Gastroenterol. 1999;94:3215–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Atkin W, Rogers P, Cardwell C, et al. Wide variation in adenoma detection rates at screening flexible sigmoidoscopy. Gastroenterology. 2004;126:1247–56.PubMedCrossRefGoogle Scholar
  36. 36.
    Pinsky PF, Schoen RE, Weissfeld JL, et al. Variability in flexible sigmoidoscopy performance among examiners in a screening trial. Clin Gastroenterol Hepatol. 2005;3:792–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Bretthauer M, Skovlund E, Grotmol T, et al. Inter-endoscopist variation in polyp and neoplasia pick-up rates in flexible sigmoidoscopy screening for colorectal cancer. Scand J Gastroenterol. 2003;38:1268–74.PubMedCrossRefGoogle Scholar
  38. 38.
    Atkin WS, Cook CF, Patel R. Variability in yield of neoplasia in average risk individuals undergoing flexible sigmoidoscopy screening. Gastrointest Endosc. 2001;120:A66.Google Scholar
  39. 39.
    •• Maslekar S, Waudby P, Avery G, et al. Quality assurance in flexible sigmoidoscopy: medical and nonmedical endoscopists. Surg Endosc. 2010;24:89–93. Important information for every endoscopist who practices flexible sigmoidoscopy. PubMedCrossRefGoogle Scholar
  40. 40.
    Shapero TF, Hoover J, Paszat LF, et al. Colorectal cancer screening with nurse-performed flexible sigmoidoscopy: results from a Canadian community-based program. Gastrointest Endosc. 2007;65:640–5.PubMedCrossRefGoogle Scholar
  41. 41.
    Schoenfeld P, Lipscomb S, Crook J, et al. Accuracy of polyp detection by gastroenterologists and nurse endoscopists during flexible sigmoidoscopy: a randomized trial. Gastroenterology. 1999;117:312–8.PubMedCrossRefGoogle Scholar
  42. 42.
    Schoenfeld PS, Cash B, Kita J, et al. Effectiveness and patient satisfaction with screening flexible sigmoidoscopy performed by registered nurses. Gastrointest Endosc. 1999;49:158–62.PubMedCrossRefGoogle Scholar
  43. 43.
    Wallace MB, Kemp JA, Meyer F, et al. Screening for colorectal cancer with flexible sigmoidoscopy by nonphysician endoscopists. Am J Med. 1999;107:214–8.PubMedCrossRefGoogle Scholar
  44. 44.
    Pinsky PF, Schoen RE, Weissfeld JL, et al. Predictors of advanced proximal neoplasia in persons with abnormal screening flexible sigmoidoscopy. Clin Gastroenterol Hepatol. 2003;1:103–10.PubMedCrossRefGoogle Scholar
  45. 45.
    Levin TR, Palitz A, Grossman S, et al. Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy. JAMA. 1999;281:1611–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Anderson JC, Alpern Z, Messina C, et al. Predictors of proximal neoplasia in patients without distal adenomatous pathology. Am J Gastroenterol. 2004;99:472–7.PubMedCrossRefGoogle Scholar
  47. 47.
    Betés Ibáñez M, Muñoz-Navas MA, Duque JM, et al. Diagnostic value of distal colonic polyps for prediction of advanced proximal neoplasia in an average-risk population undergoing screening colonoscopy. Gastrointest Endosc. 2004;59:634–41.PubMedCrossRefGoogle Scholar
  48. 48.
    Hewitson P, Glasziou P, Irwig L, et al. Screening for colorectal cancer using the faecal occult blood test, hemoccult. Cochrane Database Syst Rev. 2007;1:1216.Google Scholar
  49. 49.
    Van Rossum LG, Van Rijn AF, Laheij PF, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135:82–90.PubMedCrossRefGoogle Scholar
  50. 50.
    • Hol L, van Leerdam ME, van Ballegooijen M, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut. 2010;59:62–8. The combination of fecal occult blood test and flexible sigmoidoscopy is controversial. PubMedCrossRefGoogle Scholar
  51. 51.
    Segnan N, Senore C, Andreoni B, et al. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology. 2007;132:2304–12.PubMedCrossRefGoogle Scholar
  52. 52.
    Lieberman DA, Weiss DG. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med. 2001;345:555–60.PubMedCrossRefGoogle Scholar
  53. 53.
    Geul KW, Bosman FT, Van Blankenstein M, et al. Prevention of colorectal cancer. Costs and effectiveness of sigmoidoscopy. Scand J Gastroenterol. 1997;2:79–87.Google Scholar
  54. 54.
    Taylor SA, Halligan S, Saunders BP, et al. Acceptance by patients of multidetector CT colonography compared with barium enema examinations, flexible sigmoidoscopy, and colonoscopy. Am J Roentgenol. 2003;181:913–21.Google Scholar
  55. 55.
    Kim LS, Koch J, Yee J, et al. Comparison of patients’ experiences during imaging tests of the colon. Gastrointest Endosc. 2001;54:67–74.PubMedCrossRefGoogle Scholar
  56. 56.
    Schoen RE, Pinsky PF, Weissfeld JL, et al. Results of repeat sigmoidoscopy 3 years after a negative examination. JAMA. 2003;290:41–8.PubMedCrossRefGoogle Scholar
  57. 57.
    Bonelli L, Sciallero S, Senore C, et al. History of negative colorectal endoscopy and risk of rectosigmoid neoplasms at screening flexible sigmoidoscopy. Int J Colorectal Dis. 2006;21:105–13.PubMedCrossRefGoogle Scholar
  58. 58.
    Burke CA, Elder K, Lopez R. Screening for colorectal cancer with flexible sigmoidoscopy: is a 5-yr interval appropriate? a comparison of the detection of neoplasia 3 yr versus 5 yr after a normal examination. Am J Gastroenterol. 2006;101:1329–32.PubMedCrossRefGoogle Scholar
  59. 59.
    Whynes DK, Frew EJ, Edwards R, Atkin WS. Costs of flexible sigmoidoscopy screening for colorectal cancer in the United Kingdom. Int J Tech Assess Health Care. 2003;19:384–95.CrossRefGoogle Scholar
  60. 60.
    O'Leary BA, Olynyk JK, Neville AM, Platell CF. Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy. J Gastroenterol Hepatol. 2004;19:38–47.PubMedCrossRefGoogle Scholar
  61. 61.
    • Lansdorp-Vogelaar I, Knudsen AB, Brenner H. Cost-effectiveness of colorectal cancer screening. Epidemiol Rev. 2011;33:88–100. Evaluation of cost effectiveness is very important for choosing a method for screening colorectal cancer. PubMedCrossRefGoogle Scholar
  62. 62.
    Berry DP, Clarke P, Hardcastle JD, Vellacott KD. Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening. Brit J Surg. 1997;84:1274–6.PubMedCrossRefGoogle Scholar
  63. 63.
    Rasmussen M, Kronborg O, Fenger C, Jorgensen OD. Possible advantages and drawbacks of adding flexible sigmoidoscopy to hemoccult-II in screening for colorectal cancer. Scand J Gastroenterol. 1999;1:73–8.Google Scholar
  64. 64.
    Segnan N, Senore C, Andreoni B, et al. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Canc Inst. 2005;97:347–57.CrossRefGoogle Scholar
  65. 65.
    Sung JJ, Chan FK, Leung WK, et al. Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy. Gastroenterology. 2003;124:608–14.PubMedCrossRefGoogle Scholar
  66. 66.
    Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Canc Inst. 1993;85:1311–8.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of Gastroenterology, Rabin Medical CenterTel Aviv UniversityPetach TikvaIsrael

Personalised recommendations